US FDA/CFSAN - BSE and Cosmetics: FDA Risk Assessment and Management Perspectives
December 7, 2006
BSE
- Issues for Cosmetics
- Possible vehicle for infection
- Abraded skin, eye area, mucous membranes
- Identification of ingredient sources
- Risk Assessment: tissue, country of origin
- "Safe-sourcing" from non-BSE countries; non-BSE herds in BSE or BSE-suspect countries
- Avoid "Co-mingling" and "cross-contamination"
- Use of SRMs and other "BSE-Risk Materials"
- Tallow and Tallow Derivatives
- Gelatin and Gelatin Derivatives
